Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Schedules,Therapeutic_group
ABBVIE LIMITED,Upadacitinib,"Atopic dermatitis, moderate to severe",Upadacitinib (RINVOQÂ®),Community,Dermatologicals
